NUVB | NUVATION BIO INC

CUSIP: 67080N101

1 Funds Holding

1.3M Total Shares

$5M Total Value

$1.7B

Market Cap

—

P/E Ratio

-79.2

Forward P/E

$-0.43

EPS (TTM)

—

Dividend Yield

$534M

Cash

$57M

Total Debt

347M

Shares Out

$1.57

$9.75

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Abrams Capital Management\|David Abrams	1.3M	$5M	0.12%	$10.87	-43.49%

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2026-Q1
Abrams Capital Management	SELL	-66.7%	1.3M	$5M	$5.62
2023-Q1
The Baupost Group	SELL	EXIT	—	—	$2.06
2022-Q4
The Baupost Group	SELL	-53.9%	4.8M	$9M	$1.99
2022-Q2
The Baupost Group	SELL	-0.2%	10.4M	$34M	$4.14
2022-Q1
The Baupost Group	BUY	+21.1%	10.4M	$55M	$5.40
2021-Q1
The Baupost Group	BUY	NEW	8.6M	$82M	$10.87
Abrams Capital Management	BUY	NEW	3.8M	$34M	$10.87

6 Months Insider Sentiment

100%

Buy $0 Sell $1.2M

0 Buys

1 Sells

-1.2M Net

0 Grants

Largest

$1.2M Liu

$440K Liu

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Dec 01, 2025	Dongfang Liu	CHIEF MEDICAL OFFICER	EXERCISE	150.0K	$2.93	$440K
Dec 01, 2025	Dongfang Liu	CHIEF MEDICAL OFFICER	SELL	150.0K	$7.82	$1.2M

Institutional Ownership of NUVATION BIO INC